Goals
Over the past decade, SiMPore has developed and offered industry-leading silicon nanomembranes and BioMEMS technologies to researchers furthering the fields of life and materials sciences. SiMPore strives to be a competitive membrane company and nanotechnology company in the USA. SiMPore’s goal is to create products that bring significant value to society, its customers, employees and investors, and to do so with precision, passion and quality. SiMPore promises its innovative products will deliver superior data and superior outcomes by enabling precise capture and information-rich analysis of nanoscale specimens.
Meet Our Team
Paul Then, Chief Executive Officer
Over his four-decade career at Corning Incorporated, Paul provided leadership in a broad range of technical, commercial, and business management positions. His experiences in business development and glass-based microsystems are helping drive growth at SiMPore as a membrane company. Paul holds an M.S. in Manufacturing Engineering from Carnegie-Mellon University, a B.S. in Industrial Engineering from The Pennsylvania State University, and has completed the Fundamental Optical Design Intensive Course at the University of Rochester.
James Roussie, Chief Scientific Officer & Co-Founder
As Chief Scientific Officer, Jamie spends his days applying nanotech to biotech. With over a decade of functional experience working in technology commercialization at SiMPore, he has done everything from developing new products and creating customized solutions for customers to managing intellectual property and leading sales and marketing. He holds a Ph.D. in Biochemistry from the University of Rochester and an M.S. in Science and Technology Commercialization from the University of Texas at Austin.
Jared Carter, Program Manager
Jared applies his wide product development knowledge and expertise in engineering, silicon functionalization, and bioassays to develop innovative solutions for SiMPore’s contract supply customers.
Bruce Tolleson, Microfabrication Manager
Bruce brings extensive experience from RIT’s Semiconductor Nanofabrication Laboratory (SNL), where he led technical initiatives from 1998 through 2024. He’s been involved with SiMPore since its launch in 2007, training engineers and consulting on clean room installation. A U.S Navy veteran, Bruce led technical teams in aircraft carrier avionics and systems maintenance during his 20 years of service. He holds a BS in Electronics from the Rochester Institute of Technology.
Kate Neville, R&D Manager
Kate brings experience in scientific imaging and image processing to SiMPore, working to expand its product capabilities. With an MS in Molecular and Cell Biology from the University of Rochester, she is working to develop protocols to image EVs on SiMPore membranes for various clinical applications.
Our Board
Geoffrey Rosenberger
Board Chairman & Corporate Director
James McGrath
Corporate Director & Co-founder
Thomas Gaborski
Corporate Director & Co-founder
Kevin Parker
Corporate Director
Recent News
UR researchers develop new method for liquid biopsies
Researchers at the University of Rochester are working on a method for rapid cancer diagnosis using SiMPore’s ultrathin nanomembranes. This technique, known as catch and display for liquid biopsies (CAD-LB), captures extracellular vesicles (EVs)—nano-sized carriers of cellular information—from minimally processed blood samples. By fluorescently labeling EVs caught in the membranes’ nanopores, CAD-LB enables quick detection…
Rapid Assessment of Biomarkers on Single Extracellular Vesicles Using “Catch and Display” on Ultrathin Nanoporous Silicon Nitride Membranes
Extracellular vesicles (EVs) are lipid-bound particles shed by all cells. They are involved in cell-cell communication, but have recently gained significant interest for their potential use as diagnostics and as therapeutics. Researchers from multiple Universities recently published work demonstrating the capability of SiMPore’s Silicon Nanomembranes for catch-and-display of single EVs, enabling novel analyses of these nano-sized bio particles…
University of Rochester Researchers Develop Lung-to-Brain Tissue Chips to Study Respiratory Disease Impact on the Brain
The University of Rochester has received a $7.1 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop innovative tissue-on-chip technology. This groundbreaking research aims to explore the link between respiratory diseases, such as influenza, and neurological symptoms like brain fog. The three-year project uses microphysiological systems (MPS)—tiny chips that simulate human…
Careers at SiMPore
SiMPore is a competitive nanotechnology company in USA and we’re always looking for dedicated scientists and engineers to join our team.
View our open positions and see if SiMPore is the right fit for you.
Or, send your resume to [email protected].